Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Sign In to gain access to subscriptions and/or personal tools.
Journal of Endotoxin Research
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Villa, P.
Right arrow Articles by Ghezzi, P.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Villa, P.
Right arrow Articles by Ghezzi, P.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Protection against lethal polymicrobial sepsis by CNI-1493, an inhibitor of pro-inflammatory cytokine synthesis

P. Villa

Mario Negri Institute for Pharmacological Research, Milan, Italy, CNR Cellular and Molecular Pharmacology Center, Milan, Italy

C. Meazza

Mario Negri Institute for Pharmacological Research, Milan, Italy

M. Sironi

Mario Negri Institute for Pharmacological Research, Milan, Italy

M. Bianchi

The Picower Institute for Medical Research, Manhasset, New York, USA

P. Ulrich

The Picower Institute for Medical Research, Manhasset, New York, USA

G. Botchkina

The Picower Institute for Medical Research, Manhasset, New York, USA

K.J. Tracey

The Picower Institute for Medical Research, Manhasset, New York, USA, ktracey{at}picower.edu, Department of Surgery, North Shore University Hospital, Manhasset, New York, USA

P. Ghezzi

Mario Negri Institute for Pharmacological Research, Milan, Italy

Polymicrobial sepsis caused by cecal ligation and puncture (CLP) in mice produces the inflammatory and pathological sequelae of lung neutrophil infiltration, adult respiratory distress syndrome (ARDS) and death. These sequelae are dependent upon the synergistic interaction between several inflammatory mediators, including tumor necrosis factor (TNF), interleukin 1 (IL-1 ), and nitric oxide (NO). The overlapping spectrum of multiple mediator toxicity has hampered efforts to develop therapies for sepsis based on selective inhibition of a single mediator. Therefore, we tested the hypothesis that inhibition of multiple pro-inflammatory mediators would abrogate lethality. Our results show that administration of a tetravalent guanylhydrazone compound (CNI-1493) protected mice against 10 day mortality in CLP. Evidence of suppression of the cytokine cascade was given by decreased serum levels of TNF and IL-6 in CNI-1493 treated animals (TNF reduced 60% as compared to controls; IL-6 reduced 90% compared to controls; P < 0.05), and decreased levels of the acute-phase protein serum amyloid A response measured 24 h after CLP. Serum nitrites/nitrates, which give an index of NO production, were also significantly reduced (50%). Protection against CLP induced lung damage was observed as attenuation of edema and alveolar neutrophil infiltration, suppression of pulmonary TNF levels, and reduction of TUNEL-positive staining in lung. We conclude that CNI-1493 effectively inhibits the synthesis of multiple pro-inflammatory mediators and protects against death during polymicrobial sepsis.

Journal of Endotoxin Research, Vol. 4, No. 3, 197-204 (1997)
DOI: 10.1177/096805199700400305


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
X. Lin, H. Yang, T. Sakuragi, M. Hu, L. L. Mantell, S. Hayashi, Y. Al-Abed, K. J. Tracey, L. Ulloa, and E. J. Miller
{alpha}-Chemokine receptor blockade reduces high mobility group box 1 protein-induced lung inflammation and injury and improves survival in sepsis
Am J Physiol Lung Cell Mol Physiol, October 1, 2005; 289(4): L583 - L590.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
C. Granert, H. Abdalla, L. Lindquist, A. Diab, M. Bakhiet, K. J. Tracey, and J. Andersson
Suppression of Macrophage Activation with CNI-1493 Increases Survival in Infant Rats with Systemic Haemophilus influenzae Infection
Infect. Immun., September 1, 2000; 68(9): 5329 - 5334.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
C. A. Salkowski, G. Detore, A. Franks, M. C. Falk, and S. N. Vogel
Pulmonary and Hepatic Gene Expression following Cecal Ligation and Puncture: Monophosphoryl Lipid A Prophylaxis Attenuates Sepsis-Induced Cytokine and Chemokine Expression and Neutrophil Infiltration
Infect. Immun., August 1, 1998; 66(8): 3569 - 3578.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. M. Kemeny, G. I. Botchkina, M. Ochani, M. Bianchi, C. Urmacher, and K. J. Tracey
The tetravalent guanylhydrazone CNI-1493 blocks the toxic effects of interleukin-2 without diminishing antitumor efficacy
PNAS, April 14, 1998; 95(8): 4561 - 4566.
[Abstract] [Full Text] [PDF]